Gynaecological adverse events and hysterectomies in the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial

被引：0

作者：

Duffy, S. ^{[1
]}

机构：

[1] St James Univ Hosp, Acad Div Obstet & Gynaecol, Leeds, W Yorkshire, England

来源：

EJC SUPPLEMENTS | 2005年 / 3卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：75 / 75

页数：1

共 50 条

[41] Breast surgery in the 'Arimidex, tamoxifen alone or in combination' (ATAC) trial - American women are more likely than women from the United Kingdom to undergo mastectomy
Locker, GY
Sainsbury, JR
Cuzick, J
CANCER, 2004, 101 (04) : 735 - 740
[42] Tolerability of anastrozole (A) compared with tamoxifen (T): Mature data in the adjuvant setting - Data reported on behalf of the ATAC ('arimidex', tamoxifen, alone or in combination) trialists' group
Mansel, Robert
ANNALS OF ONCOLOGY, 2006, 17 : 94 - 94
[43] Beneficial side-effect profile of anastrozole compared with tamoxifen confirmed by additional 7 months of exposure data: a safety update from the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial
Sainsbury, R
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S156 - S156
[44] The arimidex, alone or in combination (ATAC) adjuvant breast cancer trial: Baseline endometrial sub-protocol data
Duffy, S
Jackson, TL
EUROPEAN JOURNAL OF CANCER, 2002, 38 : S83 - S83
[45] A lower incidence of gynecologic adverse events and interventions with anastrozole than with tamoxifen in the ATAC trial
Duffy, Sean R.
Distler, Wolfgang
Howell, Anthony
Cuzick, Jack
Baum, Michael
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (01) : 80.e1 - 80.e7
[46] The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy
Duffy, S
Jackson, TL
Lansdown, M
Philips, K
Wells, M
Pollard, S
Clack, G
Coibion, M
Bianco, AR
HUMAN REPRODUCTION, 2005, 20 (01) : 294 - 301
[47] Clinical trial presentations, agency guidelines, and oncology practice: Findings from the arimidex, tamoxifen, alone or in combination trial
Chlebowski, Rowan T.
CLINICAL BREAST CANCER, 2008, 8 (04) : 343 - 346
[48] Initial adjuvant therapy with anastrozole - early- and late-event data from the arimidex, tamoxifen, alone or in combination (ATAC) trial in the hormone-responsive population
Howell, A.
Forbes, J.
Cuzick, J.
BREAST, 2009, 18 : S51 - S51
[49] The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) Trial in Postmenopausal Women with Early Breast Cancer – Updated Efficacy Results Based on a Median Follow-up of 47 Months
Aman Buzdar
Breast Cancer Research and Treatment, 2003, 77 (3) : 295 - 295
[50] The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial in postmenopausal women with early breast cancer - updated efficacy results based on a median follow-up of 5 years
Howell, A
BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S7 - S7

← 1 2 3 4 5 →